Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?

Author： Akira Babazono   Motonobu Miyazaki  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.15, 2004-01, pp. : 975-983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Are Appropriate End-Points for Helicobacter pylori Eradication in the Treatment of Duodenal Ulcer?

By Williams M.P.   Pounder R.E.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite

Diclofenac: Peptic ulcer disease in a patient with Helicobacter pylori infection?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Gastric bypass surgery does not increase susceptibility to Helicobacter pylori infection in the stomach of rat or mouse

By Stenström Björn  

Inflammopharmacology, Vol. 13, Iss. 1-3, 2005-08 ,pp. : 229-234

VSP

Access to resources Recommend Favorite

Personality disorders increase costs to UK primary care?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Helicobacter Pylori and Inflammation

By  

Current Pharmaceutical Design, Vol. 16, Iss. 38, 2010-12 ,pp. : 4225-4236

Bentham Science Publishers

Access to resources Recommend Favorite